Original Research
Accepted on 26 Sep 2025
Chromosome 11q13 Amplification as a Decision-Making Biomarker for Anti-PD-1 Immunotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Prospective Cohort Study
in Cancer Immunity and Immunotherapy